Edition:
United States

Cigna Corp (CI.N)

CI.N on New York Stock Exchange

209.86USD
9:52am EST
Change (% chg)

$2.08 (+1.00%)
Prev Close
$207.78
Open
$207.24
Day's High
$210.24
Day's Low
$207.24
Volume
24,872
Avg. Vol
535,612
52-wk High
$227.12
52-wk Low
$163.02

Chart for

About

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company's segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations... (more)

Overall

Beta: 0.53
Market Cap(Mil.): $51,884.98
Shares Outstanding(Mil.): 243.53
Dividend: 0.04
Yield (%): 0.02

Financials

  CI.N Industry Sector
P/E (TTM): 17.54 23.05 29.37
EPS (TTM): 12.14 -- --
ROI: -- 0.13 13.58
ROE: 20.14 20.00 15.11

IBM a top bridge loan borrower with Red Hat buy

NEW YORK (LPC) - IBM Corp’s $20 billion loan supporting the information technology company’s purchase of US software company Red Hat Inc is one of the largest ever bridge loans for a US investment grade company and banks are keen to lend after several quiet months for big mergers and acquisitions. 

Nov 01 2018

Cigna boosts 2018 forecast after third quarter earnings beat

U.S. health insurer Cigna Corp , which is in the process of acquiring Express Scripts Holding Co , significantly bumped up its 2018 adjusted profit forecast, and its shares rose more than 3 percent on Thursday.

Nov 01 2018

UPDATE 3-Cigna boosts 2018 forecast after third quarter earnings beat

* Shares up 3.1 percent at $220.26 (Adds details from conference call, analyst quote, shares)

Nov 01 2018

Cigna's third-quarter profit rises driven by lower medical costs

Nov 1 Cigna Corp on Thursday reported a higher third quarter profit, helped by lower medical costs in its government healthcare plans.

Nov 01 2018

Express Scripts covers Amgen, Lilly migraine drugs, excludes Teva

LOS ANGELES Express Scripts Holding Co, one of the largest U.S. prescription benefits managers, will cover new migraine drugs from Eli Lilly and Amgen Inc, but exclude a rival medication from Teva Pharmaceutical Industries Ltd after price negotiations with all three manufacturers.

Oct 17 2018

Express Scripts covers Amgen, Lilly migraine drugs, excludes Teva

LOS ANGELES Express Scripts Holding Co, one of the largest U.S. prescription benefits managers, will cover new migraine drugs from Eli Lilly and Amgen Inc, but exclude a rival medication from Teva Pharmaceutical Industries Ltd after price negotiations with all three manufacturers.

Oct 17 2018

UPDATE 1-Express Scripts covers Amgen, Lilly migraine drugs, excludes Teva

LOS ANGELES Oct 17 Express Scripts Holding Co , one of the largest U.S. prescription benefits managers, will cover new migraine drugs from Eli Lilly and Amgen Inc, but exclude a rival medication from Teva Pharmaceutical Industries Ltd after price negotiations with all three manufacturers.

Oct 17 2018

CVS, Aetna win U.S. approval for $69 billion deal

WASHINGTON/NEW YORK Pharmacy chain CVS Health Corp won U.S. antitrust approval for its $69 billion acquisition of health insurer Aetna Inc , the Justice Department said on Wednesday, paving the way for a combination with potential to cut U.S. healthcare costs for consumers. | Video

Oct 10 2018

UPDATE 3-CVS, Aetna win U.S. approval for $69 bln deal

WASHINGTON/NEW YORK, Oct 10 Pharmacy chain CVS Health Corp won U.S. antitrust approval for its $69 billion acquisition of health insurer Aetna Inc, the Justice Department said on Wednesday, paving the way for a combination with potential to cut U.S. healthcare costs for consumers.

Oct 10 2018

CVS, Aetna win approval for merger

WASHINGTON, Oct 10 Pharmacy chain CVS Health Corp won U.S. antitrust approval for its $69 billion acquisition of health insurer Aetna Inc, the Justice Department said on Wednesday, paving the way for a combination the companies say can help cut soaring U.S. healthcare costs.

Oct 10 2018

Earnings vs. Estimates